Literature DB >> 1756719

Identification of a novel recognition sequence for the integrin alpha 4 beta 1 in the COOH-terminal heparin-binding domain of fibronectin.

A P Mould1, M J Humphries.   

Abstract

The type III connecting segment of fibronectin contains two cell binding sites, represented by the peptides CS1 and CS5, that are recognized by the integrin receptor alpha 4 beta 1. Using assays measuring the spreading of A375-SM human melanoma cells, we now report that the adhesion promoting activity of a 29 kDa protease fragment of fibronectin containing the COOH-terminal heparin-binding domain (HepII), but lacking CS1 and CS5, is completely sensitive to anti-alpha 4 and anti-beta 1 antibodies, suggesting that HepII contains a third alpha 4 beta 1-binding sequence. Examination of the primary structure of HepII revealed a sequence with homology to CS1. A 19mer peptide spanning this region (designated H1) was found to support cell spreading to the same level as the 29 kDa fragment. H1-dependent adhesion was completely sensitive to anti-alpha 4 and anti-beta 1 antibodies. When soluble peptides were tested for their ability to block cell spreading on the 29 kDa fragment, a 13mer peptide comprising the central core of H1 was found to be completely inhibitory. The active region of H1 was localized to the pentapeptide IDAPS, which is homologous to LDVPS from the active site of CS1. Taken together, these results identify a novel peptide sequence in the HepII region of fibronectin that supports alpha 4 beta 1-dependent cell adhesion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756719      PMCID: PMC453158          DOI: 10.1002/j.1460-2075.1991.tb04985.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  60 in total

1.  Adhesion of human T-lymphoid cells to fibronectin is mediated by two different fibronectin domains.

Authors:  A Garcia-Pardo; O C Ferreira
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

Review 2.  Cytoadhesins, integrins, and platelets.

Authors:  M H Ginsberg; J C Loftus; E F Plow
Journal:  Thromb Haemost       Date:  1988-02-25       Impact factor: 5.249

3.  Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function.

Authors:  M Obara; M S Kang; K M Yamada
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

4.  Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion.

Authors:  M J Humphries; S K Akiyama; A Komoriya; K Olden; K M Yamada
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

5.  Human B lymphocytes define an alternative mechanism of adhesion to fibronectin. The interaction of the alpha 4 beta 1 integrin with the LHGPEILDVPST sequence of the type III connecting segment is sufficient to promote cell attachment.

Authors:  A Garcia-Pardo; E A Wayner; W G Carter; O C Ferreira
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

6.  Adhesion of lymphoid cells to the carboxyl-terminal heparin-binding domains of fibronectin.

Authors:  N S Liao; J ST John; J B McCarthy; L T Furcht; H T Cheung
Journal:  Exp Cell Res       Date:  1989-04       Impact factor: 3.905

7.  Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene.

Authors:  A R Kornblihtt; K Umezawa; K Vibe-Pedersen; F E Baralle
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

8.  Lymphoid precursor cells adhere to two different sites on fibronectin.

Authors:  P Bernardi; V P Patel; H F Lodish
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

9.  Selective interaction of peripheral and central nervous system cells with two distinct cell-binding domains of fibronectin.

Authors:  S L Rogers; P C Letourneau; B A Peterson; L T Furcht; J B McCarthy
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

10.  Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin.

Authors:  E A Wayner; A Garcia-Pardo; M J Humphries; J A McDonald; W G Carter
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

View more
  42 in total

1.  Crystal structure of a heparin- and integrin-binding segment of human fibronectin.

Authors:  A Sharma; J A Askari; M J Humphries; E Y Jones; D I Stuart
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Identification of a neurite outgrowth-promoting motif within the alternatively spliced region of human tenascin-C.

Authors:  S Meiners; M S Nur-e-Kamal; M L Mercado
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 3.  Fibronectin: functional character and role in alcoholic liver disease.

Authors:  Razia S Aziz-Seible; Carol A Casey
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

4.  Beta1 and beta3 integrins cooperate to induce syndecan-4-containing cross-linked actin networks in human trabecular meshwork cells.

Authors:  Mark S Filla; Anne Woods; Paul L Kaufman; Donna M Peters
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

5.  Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells.

Authors:  M J Hewish; Y Takada; B S Coulson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 6.  Erythroblastic islands: niches for erythropoiesis.

Authors:  Joel Anne Chasis; Narla Mohandas
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

7.  Characterization of mouse fibronectin alternative mRNAs reveals an unusual isoform present transiently during liver development.

Authors:  G K Górski; M C Aros; P A Norton
Journal:  Gene Expr       Date:  1996

8.  Consensus motif for integrin transmembrane helix association.

Authors:  Bryan W Berger; Daniel W Kulp; Lisa M Span; Jessica L DeGrado; Paul C Billings; Alessandro Senes; Joel S Bennett; William F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-18       Impact factor: 11.205

9.  Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance.

Authors:  Marek Mraz; Clive S Zent; Amy K Church; Diane F Jelinek; Xiaosheng Wu; Sarka Pospisilova; Stephen M Ansell; Anne J Novak; Neil E Kay; Thomas E Witzig; Grzegorz S Nowakowski
Journal:  Br J Haematol       Date:  2011-07-12       Impact factor: 6.998

Review 10.  Cartilage destruction by matrix degradation products.

Authors:  Tadashi Yasuda
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.